Influence of use of a vascular closure device on incidence and surgical management of access site complications after percutaneous interventions.

[1]  P. Lin,et al.  Access site management with vascular closure devices for percutaneous transarterial procedures. , 2010, Journal of vascular surgery.

[2]  F. Biancari,et al.  Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. , 2010, American heart journal.

[3]  L. S. Schultze Kool,et al.  Acute arterial occlusion after deployment of the Angio-Seal closure device: is it as uncommon as we think? , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  J. M. Bernal,et al.  Surgical treatment of arterial ischemia associated with the use of the angioseal vascular closure device. , 2009, VASA. Zeitschrift fur Gefasskrankheiten.

[5]  R. Wilensky,et al.  Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention. , 2009, The Journal of invasive cardiology.

[6]  J. A. Molnar,et al.  Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy. , 2008, Journal of vascular and interventional radiology : JVIR.

[7]  R. Veasey,et al.  A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital – the SCOAST study , 2008, International journal of clinical practice.

[8]  R. P. Vermeulen,et al.  Closure of the femoral artery after cardiac catheterization: A comparison of Angio‐Seal, StarClose, and manual compression , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  T. Carrel,et al.  Complications Associated With the Arterial Puncture Closure Device—Angio-Seal , 2008, Vascular and endovascular surgery.

[10]  H. Dauerman,et al.  Vascular closure devices: the second decade. , 2007, Journal of the American College of Cardiology.

[11]  Z. Krasiński,et al.  Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation. , 2007, International journal of cardiology.

[12]  Patanjali Chaturvedi.  Prospective Nonrandomized Trial of Manual Compression and Angio-Seal and StarClose Arterial Closure Devices in Common Femoral Punctures , 2007, CardioVascular and Interventional Radiology.

[13]  J. Tijssen,et al.  Randomized Trial Comparing Same-Day Discharge With Overnight Hospital Stay After Percutaneous Coronary Intervention: Results of the Elective PCI in Outpatient Study (EPOS) , 2007, Circulation.

[14]  M. Matheny,et al.  A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. , 2007, American heart journal.

[15]  E. Dregelid,et al.  Complications associated with the Angio-Seal arterial puncture closing device: intra-arterial deployment and occlusion by dissected plaque. , 2006, Journal of vascular surgery.

[16]  Deepak L. Bhatt,et al.  The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. , 2006, Journal of the American College of Cardiology.

[17]  P. Desgranges,et al.  The safety and efficacy of angioseal in therapeutic endovascular interventions. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  J. Bacharach,et al.  Claudication secondary to Perclose use after percutaneous procedures , 2006 .

[19]  J. Albes,et al.  Intravascular misplacement of an extravascular closure system: StarClose. , 2006, Journal of interventional cardiology.

[20]  J. P. Vries,et al.  Acute Leg Ischemia: The Dark Side of a Percutaneous Femoral Artery Closure Device , 2006, Annals of vascular surgery.

[21]  S. Şahin,et al.  Evaluation of risk factors associated with femoral pseudoaneurysms after cardiac catheterization. , 2006, Journal of vascular surgery.

[22]  W. Little,et al.  Vascular complications with newer generations of angioseal vascular closure devices. , 2006, Journal of interventional cardiology.

[23]  R. Brindis,et al.  Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II. , 2005, The Journal of invasive cardiology.

[24]  A. Yeung,et al.  Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. , 2005, Journal of the American College of Cardiology.

[25]  G. Stone,et al.  Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. , 2004, Journal of the American College of Cardiology.

[26]  S. Katz,et al.  The use of the Angioseal device for femoral artery closure. , 2004, Journal of vascular surgery.

[27]  C. Thalhammer,et al.  Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterisation. , 2004, VASA. Zeitschrift fur Gefasskrankheiten.

[28]  P. Vaitkus.  A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. , 2004, The Journal of invasive cardiology.

[29]  M. Müllner,et al.  Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.

[30]  B. Chevalier,et al.  Effect of a closure device on complication rates in high‐local‐risk patients: Results of a randomized multicenter trial , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  L. Michalis,et al.  A Prospective Randomized Trial Comparing the Safety and Efficacy of Three Commercially Available Closure Devices (Angioseal, Vasoseal and Duett) , 2002, CardioVascular and Interventional Radiology.

[32]  T. Craven,et al.  Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. , 2002, Journal of the American College of Cardiology.

[33]  G. Stone,et al.  Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. , 2001, Journal of the American College of Cardiology.

[34]  E. Topol,et al.  Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. , 2000, The American journal of cardiology.

[35]  D. Baim,et al.  Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. , 2000, The American journal of cardiology.

[36]  J. Eidt,et al.  Surgical complications from hemostatic puncture closure devices. , 1999, American journal of surgery.

[37]  S. Warren,et al.  Predictors of complications and learning curve using the Angio‐SealTM closure device following interventional and diagnostic catheterization , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[38]  G. Roubin,et al.  A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. , 1999, The Journal of invasive cardiology.

[39]  C. Moore,et al.  Complications of femoral artery closure devices , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  W. Knopf,et al.  Outpatient PTCA with same day discharge is safe and produces high patient satisfaction level. , 1999, The Journal of invasive cardiology.

[41]  C. Simpfendorfer,et al.  Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. , 1998, The American journal of cardiology.

[42]  C. Simpfendorfer,et al.  Efficacy and Safety of a Hemostatic Puncture Closure Device With Early Ambulation After Coronary Angiography fn1 , 1998 .

[43]  E. Nylander,et al.  Vascular injury following cardiac catheterization, coronary angiography, and coronary angioplasty. , 1994, European heart journal.

[44]  J. Brinker,et al.  A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. , 1993, Journal of the American College of Cardiology.

[45]  R. Shaw,et al.  CORONARY ARTERY DISEASE Original Studies Angiographic Predictors of Femoral Access Site Complications: Implication for Planned Percutaneous Coronary Intervention , 2005 .

[46]  R. Brindis,et al.  Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. , 2004, The Journal of invasive cardiology.